Iyama S - Search Results

1

Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.

Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, Hamada S, Iyama S, Saruwatari K, Saeki S, Takahashi M, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: iyama s. Oncoimmunology. 2022 May 27;11(1):2081010. doi: 10.1080/2162402X.2022.2081010. eCollection 2022. Oncoimmunology. 2022. PMID: 35655708 Free PMC article.

2

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K. Akaike K, et al. Among authors: iyama s. Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020. Anticancer Res. 2018. PMID: 30396984

3

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H, Fujii K, Tomita Y. Jodai T, et al. Among authors: iyama s. Immun Inflamm Dis. 2019 Mar;7(1):3-6. doi: 10.1002/iid3.238. Epub 2018 Nov 21. Immun Inflamm Dis. 2019. PMID: 30461210 Free PMC article.

4

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.

Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K, Ishizuka S, Sato N, Saruwatari K, Saeki S, Tomita Y, Sakagami T. Sato R, et al. Among authors: iyama s. J Clin Med. 2019 May 29;8(6):762. doi: 10.3390/jcm8060762. J Clin Med. 2019. PMID: 31146442 Free PMC article.

5

Predictive value of ¹⁸F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy.

Akaike K, Saruwatari K, Oda S, Shiraishi S, Takahashi H, Hamada S, Iyama S, Horio Y, Tomita Y, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Sakagami T. Akaike K, et al. Among authors: iyama s. Int J Clin Oncol. 2020 Apr;25(4):681-690. doi: 10.1007/s10147-019-01584-x. Epub 2019 Nov 28. Int J Clin Oncol. 2020. PMID: 31781994

6

Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.

Tomita Y, Ikeda T, Sakata S, Saruwatari K, Sato R, Iyama S, Jodai T, Akaike K, Ishizuka S, Saeki S, Sakagami T. Tomita Y, et al. Among authors: iyama s. Cancer Immunol Res. 2020 Oct;8(10):1236-1242. doi: 10.1158/2326-6066.CIR-20-0051. Epub 2020 Jul 14. Cancer Immunol Res. 2020. PMID: 32665261

7

Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics.

Migiyama Y, Sakata S, Iyama S, Tokunaga K, Saruwatari K, Tomita Y, Saeki S, Okamoto S, Ichiyasu H, Sakagami T. Migiyama Y, et al. Among authors: iyama s. Crit Care. 2021 Feb 11;25(1):59. doi: 10.1186/s13054-021-03488-7. Crit Care. 2021. PMID: 33573691 Free PMC article.

8

Clinical impact of cerebral infarction in patients with non-small cell lung cancer.

Anai M, Saruwatari K, Ikeda T, Oda S, Tajima Y, Jodai T, Sakata S, Iyama S, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Anai M, et al. Among authors: iyama s. Int J Clin Oncol. 2022 May;27(5):863-870. doi: 10.1007/s10147-022-02132-w. Epub 2022 Feb 22. Int J Clin Oncol. 2022. PMID: 35192084

9

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer.

Imamura K, Tomita Y, Sato R, Ikeda T, Iyama S, Jodai T, Takahashi M, Takaki A, Akaike K, Hamada S, Sakata S, Saruwatari K, Saeki S, Ikeda K, Suzuki M, Sakagami T. Imamura K, et al. Among authors: iyama s. Int J Mol Sci. 2022 Nov 8;23(22):13723. doi: 10.3390/ijms232213723. Int J Mol Sci. 2022. PMID: 36430217 Free PMC article.

10

Interstitial Lung Disease in Adulthood Associated with Surfactant Protein C Gene Mutation in a Patient with a History of Lipoid Pneumonia in Infancy.

Furukawa T, Akaike K, Iyama S, Masunaga A, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Furukawa T, et al. Among authors: iyama s. Intern Med. 2023 Sep 1;62(17):2521-2525. doi: 10.2169/internalmedicine.0980-22. Epub 2023 Jan 15. Intern Med. 2023. PMID: 36642519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters